NO2002010I2 - Ertapenem - Google Patents

Ertapenem

Info

Publication number
NO2002010I2
NO2002010I2 NO2002010C NO2002010C NO2002010I2 NO 2002010 I2 NO2002010 I2 NO 2002010I2 NO 2002010 C NO2002010 C NO 2002010C NO 2002010 C NO2002010 C NO 2002010C NO 2002010 I2 NO2002010 I2 NO 2002010I2
Authority
NO
Norway
Prior art keywords
ertapenem
Prior art date
Application number
NO2002010C
Other languages
English (en)
Other versions
NO2002010I1 (no
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Publication of NO2002010I1 publication Critical patent/NO2002010I1/no
Publication of NO2002010I2 publication Critical patent/NO2002010I2/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings
NO2002010C 1992-02-04 2002-10-09 Ertapenem NO2002010I2 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929202298A GB9202298D0 (en) 1992-02-04 1992-02-04 Antibiotic compounds
PCT/GB1993/000217 WO1993015078A1 (en) 1992-02-04 1993-02-02 Carbapenems containing a carboxy substituted phenyl group, processes for their preparation, intermediates and use as antibiotics

Publications (2)

Publication Number Publication Date
NO2002010I1 NO2002010I1 (no) 2002-10-09
NO2002010I2 true NO2002010I2 (no) 2005-03-11

Family

ID=10709764

Family Applications (2)

Application Number Title Priority Date Filing Date
NO933530A NO304315B1 (no) 1992-02-04 1993-10-01 Karbapenemer inneholdene en karboksysubstituert fenylgruppe, mellomprodukter for fremstilling derav, og farmas°ytiske preparater inneholdende dem
NO2002010C NO2002010I2 (no) 1992-02-04 2002-10-09 Ertapenem

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO933530A NO304315B1 (no) 1992-02-04 1993-10-01 Karbapenemer inneholdene en karboksysubstituert fenylgruppe, mellomprodukter for fremstilling derav, og farmas°ytiske preparater inneholdende dem

Country Status (35)

Country Link
US (7) US5478820A (no)
EP (1) EP0579826B1 (no)
JP (1) JP2730600B2 (no)
KR (1) KR100200986B1 (no)
CN (1) CN1036006C (no)
AP (1) AP398A (no)
AT (1) ATE173262T1 (no)
AU (1) AU668133B2 (no)
CA (1) CA2106370C (no)
CZ (1) CZ286878B6 (no)
DE (2) DE10299041I2 (no)
DK (1) DK0579826T3 (no)
ES (1) ES2123654T3 (no)
FI (1) FI104074B (no)
GB (2) GB9202298D0 (no)
GE (1) GEP20022694B (no)
HK (1) HK1013998A1 (no)
HR (1) HRP930103B1 (no)
HU (3) HU213675B (no)
IL (1) IL104588A (no)
LU (1) LU90970I2 (no)
MY (1) MY111685A (no)
NL (1) NL300104I2 (no)
NO (2) NO304315B1 (no)
NZ (2) NZ272038A (no)
PL (3) PL174649B1 (no)
RU (1) RU2117659C1 (no)
SG (1) SG48817A1 (no)
SI (1) SI9300056B (no)
SK (1) SK280890B6 (no)
TW (1) TW408124B (no)
UA (1) UA44885C2 (no)
WO (1) WO1993015078A1 (no)
YU (1) YU48998B (no)
ZA (1) ZA93453B (no)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2106330A1 (en) * 1992-10-07 1994-04-08 Patrice J. Siret Antibiotic compounds
US5602118A (en) * 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems
GB9515975D0 (en) 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
HRP970281B1 (en) * 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation
UA62920C2 (en) * 1996-05-28 2004-01-15 Merck & Co Inc Carbapeneme antibiotic, a composition and a method for the preparation
AR008255A1 (es) * 1996-07-12 1999-12-29 Merck & Co Inc Procedimiento para sintetizar antibioticos de carbapenem
AU4020897A (en) 1996-08-17 1998-03-06 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
US5877328A (en) * 1996-10-10 1999-03-02 Merck & Co., Inc. Process for synthesizing carbapenem side chain intermediates
EP0934324B1 (en) * 1996-10-10 2002-12-18 Merck & Co., Inc. (a New Jersey corp.) Process for synthesizing carbapenem side chain intermediates
AU725298B2 (en) * 1996-10-28 2000-10-12 Merck & Co., Inc. Stabilized carbapenem antibiotic compositions and method of making
US6180783B1 (en) 1997-06-16 2001-01-30 Merck & Co., Inc. Stabilized carbapenem intermediates and improved process for carbapenem synthesis
SK179799A3 (en) * 1997-06-16 2000-09-12 Merck & Co Inc Stabilized carbapenem intermediates and synthetic use
US5965747A (en) * 1997-07-10 1999-10-12 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
CA2294341C (en) * 1997-07-10 2007-09-25 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
US5872250A (en) * 1997-07-30 1999-02-16 Merck & Co., Inc. Process for synthesizing carbapenem antibiotics
AU749234B2 (en) * 1998-03-02 2002-06-20 Merck Sharp & Dohme Corp. Process for synthesizing carbapenem antibiotics
US6504027B1 (en) 1998-03-02 2003-01-07 Merck & Co., Inc. Decarboxylation process for synthesizing carbapenem antibiotics
ES2217768T3 (es) 1998-06-17 2004-11-01 MERCK & CO., INC. Procedimiento para la sintesis de intermedios de carbapenem.
US6486150B2 (en) 1999-10-29 2002-11-26 Merck & Co., Inc. Process for formulation of antibiotic compounds
US6548492B1 (en) 1999-10-29 2003-04-15 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
GB9930318D0 (en) * 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930317D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
AR035728A1 (es) * 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
WO2003026572A2 (en) * 2001-09-26 2003-04-03 Merck & Co., Inc. Crystalline forms of ertapenem sodium
MXPA04002797A (es) 2001-09-26 2004-07-02 Merck & Co Inc Procedimiento para elaborar compuestos de carbapenemo.
EP1446009A2 (en) * 2001-11-08 2004-08-18 Merck & Co., Inc. Compounds useful in the treatment of anthrax
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
IL165259A0 (en) * 2002-05-29 2005-12-18 Merck & Co Inc Compounds useful in the treatment of anthraxa and inhibiting lethal factor
EP1747550A2 (en) * 2004-05-07 2007-01-31 Infinium Labs, Inc. Multi-position multi-level user interface system
EP1747212A4 (en) * 2004-05-11 2009-03-25 Merck & Co Inc PROCESS FOR PRODUCING N-SULFINATED AMINO ACID DERIVATIVES
US20100003276A1 (en) * 2004-12-07 2010-01-07 Hermes Jeffery D Methods for treating anthrax and inhibiting lethal factor
CN100344613C (zh) * 2005-10-20 2007-10-24 上海交通大学 (2s,4s)－1－(4－硝基苄氧羰基)－2－[(3－烯丙氧羰基)－苯基氨基甲酰基]－吡咯烷－4－基硫醇的制备方法
US8901293B2 (en) * 2005-12-07 2014-12-02 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
AU2012233003B2 (en) * 2005-12-07 2014-12-18 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
WO2008062279A2 (en) * 2006-11-20 2008-05-29 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of carbapenem antibiotic
CN101357916B (zh) * 2007-06-22 2010-12-15 山东轩竹医药科技有限公司 含有二氢咪唑甲酰胺基的培南化合物
CN101367807B (zh) * 2007-06-28 2011-01-12 山东轩竹医药科技有限公司 被巯基吡咯烷甲酰胺基吡啶取代的培南衍生物
CN101367815B (zh) * 2007-06-28 2012-07-04 山东轩竹医药科技有限公司 六元环甲酰胺取代的巯基吡咯烷碳青霉烯化合物
CN101362760B (zh) * 2007-08-07 2010-12-15 山东轩竹医药科技有限公司 1β-甲基碳代青霉烯化合物
CN101362761B (zh) * 2007-08-12 2011-05-18 山东轩竹医药科技有限公司 含有巯基哌啶的碳代青霉烯抗生素
CN101412720B (zh) * 2007-08-27 2011-05-18 山东轩竹医药科技有限公司 含有巯基氮杂环乙烯基的碳青霉烯化合物
CN101376641B (zh) * 2007-08-28 2010-12-08 上海医药工业研究院 碳青霉烯类青霉素厄他培南的中间体及其制备方法和应用
EP2505191A1 (en) 2008-06-11 2012-10-03 Ranbaxy Laboratories Limited Lyophilized Carbapenem antibiotic composition
KR20110049823A (ko) * 2008-07-30 2011-05-12 랜박시 래보러터리스 리미티드 카르바페넴 화합물의 제조 방법
BRPI0913709A2 (pt) * 2008-09-18 2015-10-13 Manu Chaudhary "formulação farmacêutica"
WO2010124531A1 (zh) 2009-04-30 2010-11-04 石药集团中奇制药技术（石家庄）有限公司 一种厄他培南中间体、含其的组合物及其制备方法
WO2011048583A1 (en) 2009-10-23 2011-04-28 Ranbaxy Laboratories Limited Process for the preparation of carbapenem compounds
US8729260B2 (en) 2010-05-19 2014-05-20 Savior Lifetec Corporation Process for the preparation of carbapenem using cabapenem intermediates and recovery of cabapenem
CN102558182B (zh) * 2010-12-31 2015-02-11 石药集团中奇制药技术（石家庄）有限公司 一种厄他培南钠晶型及其制备方法
US8691803B2 (en) 2011-01-24 2014-04-08 Savior Lifetec Corporation Process for the preparation of antibiotic compounds
WO2013121279A2 (en) * 2012-02-14 2013-08-22 Aurobindo Pharma Limited Process to prepare ertapenem
WO2014057079A1 (en) * 2012-10-12 2014-04-17 Sandoz Ag Preparation of ertapenem intermediates
CA2906689A1 (en) * 2013-03-15 2014-09-18 Kala Pharmaceuticals, Inc. Meropenem derivatives and uses thereof
WO2015087245A1 (en) 2013-12-11 2015-06-18 Unimark Remedies Ltd. Process for preparation of ertapenem and salts thereof
US11180504B2 (en) 2016-03-16 2021-11-23 Orchid Pharma Ltd. Substituted carbapenems for the treatment of bacterial infections
CN106565579A (zh) * 2016-06-26 2017-04-19 宁夏海诚电化信息科技有限公司 一种尔它培南侧链生产工艺
CN110698480B (zh) * 2018-07-09 2023-09-08 武汉启瑞药业有限公司 一种厄他培南中间体的合成及纯化方法
BR112021014509A2 (pt) * 2019-01-23 2021-09-28 Glycolysis Biomed Co., Ltd Compostos de beta-lactama ou sais dos mesmos para uso na prevenção de ação prolongada ou tratamento de um transtorno de metabolismo de glicose

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208422A (en) * 1978-10-24 1980-06-17 Merck & Co., Inc. 1-Substituted-pen-2-em-3-carboxylic acids
US4232036A (en) * 1978-10-24 1980-11-04 Merck & Co., Inc. 6-, 1- and 2-Substituted-1-carbadethiapen-2-em-3-carboxylic acids
US4206219A (en) * 1978-10-24 1980-06-03 Merck & Co., Inc. 6- and 1-Substituted-1-carbadethiapen-2-em-3-carboxylic acid
US4218462A (en) * 1978-10-24 1980-08-19 Merck & Co., Inc. 6-(1-Hydroxyethyl)-2-(2-aminoethylthio)-1-substituted-1-carbade-thiapen-2-em-3-carboxylic acids
DK165280A (da) * 1979-04-19 1980-10-20 Merck & Co Inc Fremgangsmaade til fremstilling af 2- og 6-substituerede 1-carbadethiapen-2-em-3-carboxylsyrer og mellemprodukter til brug ved udoevelse af fremgangsmaaden
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体
JPS60233076A (ja) * 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
DE3579888D1 (de) * 1984-11-08 1990-10-31 Sumitomo Pharma Carbapenemverbindungen und deren herstellung.
FI81576C (fi) * 1984-12-25 1990-11-12 Sankyo Co Foerfarande foer framstaellning av derivat av 6-(1-hydroxietyl)-2-(1,2-disubstituerade-4-pyrrolidinyltio)-2- karbapenem-3-karboxylsyra, vilka aer anvaendbara som laekemedel.
EP0243686B1 (en) * 1986-03-27 1992-07-15 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production
US4974544A (en) * 1986-10-07 1990-12-04 Ricoh Company, Co. Vapor deposition apparatus
US5194624A (en) * 1988-05-23 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Intermediates for the preparation of compounds of antimicrobial activity
US4963544A (en) * 1988-05-23 1990-10-16 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
GB8923844D0 (en) * 1989-10-23 1989-12-13 Fujisawa Pharmaceutical Co Carbapenem compounds
IE910606A1 (en) * 1990-02-23 1991-08-28 Sankyo Co Carbapenem derivatives having antibiotic activity, their¹preparation and their use
US5554606A (en) * 1990-03-12 1996-09-10 Zeneca Limited Antibiotic compounds
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
GB9107341D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
GB9107342D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
CA2070305A1 (en) * 1991-06-04 1992-12-05 Isao Kawamoto 1-methylcarbapenem derivatives, their preparation and their use as antibiotics
ZA929008B (en) * 1991-12-13 1993-05-21 Bristol Myers Squibb Co Piperazinyl- and piperidinyl-cyclohexanols.
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2091309A1 (en) * 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds
GB9304156D0 (en) * 1992-03-26 1993-04-21 Zeneca Ltd Antibiotic compounds
CA2099811A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2099818A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2099817A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2106141A1 (en) * 1992-09-28 1994-03-29 Michael J. Betts Antibiotic compounds

Also Published As

Publication number Publication date
HU213675B (en) 1997-09-29
GB9300456D0 (en) 1993-03-03
SI9300056A (en) 1993-09-30
NZ246917A (en) 1995-09-26
HU211840A9 (en) 1995-12-28
HRP930103A2 (en) 1994-12-31
UA44885C2 (uk) 2002-03-15
YU5493A (sh) 1996-05-20
PL174649B1 (pl) 1998-08-31
CN1079224A (zh) 1993-12-08
PL174601B1 (pl) 1998-08-31
EP0579826A1 (en) 1994-01-26
DE69322007T2 (de) 1999-04-01
SK106393A3 (en) 1994-04-06
CA2106370A1 (en) 1993-08-05
NO304315B1 (no) 1998-11-30
SI9300056B (sl) 2000-02-29
HRP930103B1 (en) 1999-12-31
HUT64764A (en) 1994-02-28
CA2106370C (en) 2003-11-25
DK0579826T3 (da) 1999-07-26
NO2002010I1 (no) 2002-10-09
IL104588A (en) 1999-03-12
GB9202298D0 (en) 1992-03-18
US5652233A (en) 1997-07-29
RU2117659C1 (ru) 1998-08-20
HK1013998A1 (en) 1999-09-17
US20020042408A1 (en) 2002-04-11
JP2730600B2 (ja) 1998-03-25
CZ286878B6 (en) 2000-07-12
MY111685A (en) 2000-11-30
FI104074B1 (fi) 1999-11-15
AU3457493A (en) 1993-09-01
NL300104I2 (nl) 2003-02-03
US5856321A (en) 1999-01-05
NO933530L (no) 1993-10-04
LU90970I2 (fr) 2002-12-09
DE10299041I1 (de) 2003-02-20
IL104588A0 (en) 1993-06-10
US5478820A (en) 1995-12-26
FI930474A (fi) 1993-08-05
US7041836B2 (en) 2006-05-09
AP9300480A0 (en) 1993-01-31
WO1993015078A1 (en) 1993-08-05
YU48998B (sh) 2003-04-30
NL300104I1 (nl) 2002-12-02
CN1036006C (zh) 1997-10-01
TW408124B (en) 2000-10-11
FI930474A0 (fi) 1993-02-03
AP398A (en) 1995-08-29
FI104074B (fi) 1999-11-15
US20030144264A1 (en) 2003-07-31
US7342005B2 (en) 2008-03-11
GEP20022694B (en) 2002-05-10
EP0579826B1 (en) 1998-11-11
ZA93453B (en) 1993-08-05
PL174936B1 (pl) 1998-10-30
US20050209212A1 (en) 2005-09-22
AU668133B2 (en) 1996-04-26
HU9302777D0 (en) 1993-12-28
SK280890B6 (sk) 2000-09-12
SG48817A1 (en) 1998-05-18
US6521612B2 (en) 2003-02-18
ATE173262T1 (de) 1998-11-15
NZ272038A (en) 1997-07-27
JPH06506704A (ja) 1994-07-28
CZ206793A3 (en) 1994-04-13
KR100200986B1 (ko) 1999-06-15
HUT66514A (en) 1994-12-28
US6187804B1 (en) 2001-02-13
ES2123654T3 (es) 1999-01-16
NO933530D0 (no) 1993-10-01
DE69322007D1 (de) 1998-12-17
DE10299041I2 (de) 2003-06-12

Similar Documents

Publication Publication Date Title
NO2002010I1 (no) Ertapenem
NO308752B1 (no) Produksjonsnippel
FI933625A0 (fi) Filtreringsanordning
AT399443B (de) Sportschuh
ATA236892A (de) Rotornut
FI933019A (fi) Bensotiazepin- och bensoxatzepinderivat
FI931970A0 (fi) Hyvelmaskin
NO931101D0 (no) Stroembryteranordning
FIU920064U0 (fi) Kvitteringspenna
ATA227792A (de) Sportschuh
NO932590D0 (no) Tiadiazinoner
FI930438A (fi) Bredbandsmottagare
PT8484T (pt) Sacarrolhas aperfeicoado
FI179U1 (fi) Foerpackningsunderlag
FI170U1 (fi) Faesten foer exempelvis bastulave
FI648U1 (fi) Friskluftventil
FI573U1 (fi) Resetandborste
FI424U1 (fi) Gungande leksak
FI327U1 (fi) Utbredningsanordning foer vaegbyggnadsmaterialier
FI303U1 (fi) Samlare foer borrdamm
FI139U1 (fi) Faestningsorgan
FIU920124U0 (fi) Genomfoeringselement
SE9201832D0 (sv) Partikelfaella
FI935230A0 (fi) Lagerkonstruktionsgrupp
SE9201005D0 (sv) Kryckkaepp